Atlas Trials

Choroidal Neovascularization Secondary to Pathologic Myopia

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Choroidal Neovascularization Secondary to Pathologic Myopia

RecordFirmDate
A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia (NCT06176352)Hoffmann-La Roche2024-03-06
A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia. (NCT02034006)Novartis Pharmaceuticals2014-06-10

Track Choroidal Neovascularization Secondary to Pathologic Myopia automatically

Every clearance here is in the API, with alerts when new ones post.